全球更年期市場 - 市場規模、份額和增長分析：按應用（測試、診斷）、最終用戶（醫院、診斷中心） - 行業預測（2023-2030）

2021年全球更年期市場價值將達到160.1億美元，2022年將達到169億美元。 預計該市場在預測期內（2023-2030年）複合年增長率為5.33%，到2030年將擴大至244億美元。

更年期是一個自然的生物學階段，標誌著女性生育年齡的結束。 它通常發生在45歲至55歲之間，以月經停止為特徵。 經歷更年期的女性會出現各種症狀，包括潮熱、盜汗、情緒低落和陰道乾燥。

更年期及其相關症狀的流行導致旨在幫助女性應對這些症狀的產品市場不斷增長。 這個市場包括營養補充劑、草藥、維生素、礦物質和其他營養補充劑，以及非處方藥和處方藥。 這些產品旨在為經歷更年期症狀的女性提供緩解和支持。

更年期市場受到人口老齡化、意識提高、生活方式影響和技術進步等多種因素的推動。 此外，對更年期態度的改變以及醫療保健獲取和負擔能力的改善也有助於市場增長。

隨著世界人口老齡化，經歷更年期的女性人數不斷增加，導致更年期相關產品和服務的市場擴大。 隨著許多地區預期壽命的延長和生育率的下降，這種人口趨勢預計將持續下去。 例如，在美國，估計每年有 200 萬女性經歷更年期，相當於每天約有 6,000 名女性經歷更年期。 據聯合國統計，2020年50歲以上女性將有9.85億，預計到2050年將達到16.5億。

社會對更年期及其症狀的認識不斷增強，對更年期相關產品的市場做出了重大貢獻。 女性對與更年期相關的變化和健康風險越來越了解，導致對幫助管理更年期症狀的產品和服務的需求增加。 激素療法、草藥補充劑和生活方式調整是這種日益增強的意識尋求的一些解決方案。

本報告考察了全球更年期市場，並提供了市場概述以及按應用、最終用戶、地區和進入市場的公司概況劃分的趨勢。

內容

執行摘要

母公司市場分析

市場規模

• 市場動態
• 驅動程序
• 機會
• 制約因素
• 任務

主要市場洞察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 知識產權分析
• 趨勢分析
• 啟動分析
• 原材料分析
• 創新矩陣
• 管道產品分析
• 宏觀經濟指標
• 熱門投資分析
• 關鍵成功因素
• 爭用程度

市場動態與展望

• 市場動態
• 驅動程序
• 機會
• 制約因素
• 任務
• 監管狀況
• 波特分析

全球更年期市場（按應用）

• 市場概況
• 檢查、診斷

全球更年期市場，按最終用戶劃分

• 市場概況
• 醫院
• 診斷中心
• 其他

全球更年期市場（按地區）

• 市場概況
• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲

競爭格局

• 主要公司簡介
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Allergan plc
  • TherapeuticsMD Inc.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Merck & Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Amgen Inc.
  • AbbVie Inc
  • Pfizer Inc.
  • Novartis International AG
  • Procter & Gamble Co.
  • Roche Holding AG
  • Sanofi SA
  • Serenity Pharmaceuticals LLC
  • Mithra Pharmaceuticals SA

Menopause Market size was valued at USD 16.01 billion in 2021 and is poised to grow from USD 16.9 billion in 2022 to USD 24.4 billion by 2030, growing at a CAGR of 5.33% in the forecast period (2023-2030).

Menopause is a natural biological phase that signifies the end of a woman's reproductive years. Typically occurring between the ages of 45 and 55, it is characterized by the cessation of menstrual periods. Women going through menopause may encounter various symptoms, such as hot flashes, night sweats, mood swings, and vaginal dryness.

As a result of the prevalence of menopause and the associated symptoms, there is a growing market for products aimed at helping women manage these effects. This market includes nutritional supplements, herbal remedies, vitamins, minerals, and other dietary supplements, as well as over-the-counter and prescription medications. These products are designed to provide relief and support for women experiencing menopausal symptoms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Menopause Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segmental Analysis

Global Menopause Market is segmented based on treatment, and region. Based on treatment, the market is segmented into dietary supplements, OTC pharma products. Further, OTC pharma products is segmented into hormonal and non-hormonal. Based on region, the global Menopause Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The menopause market is being driven by various factors, including the aging population, increased awareness, lifestyle influences, and advancements in technology. Additionally, changing attitudes towards menopause and improved healthcare access and affordability are contributing to market growth.

As the global population ages, more women will go through menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue as life expectancies increase and birth rates decline in many regions. For example, in the United States, an estimated 2 million women experience menopause each year, which amounts to approximately 6,000 women daily. According to UN statistics, there were 985 million women aged 50 years or older in 2020, and this number is projected to reach 1.65 billion by 2050.

Growing public awareness of menopause and its symptoms has significantly contributed to the market for menopause products. Women are becoming more informed about the changes and health risks associated with menopause, leading to an increased demand for goods and services that can help manage menopause symptoms. Hormone therapy, herbal supplements, and lifestyle adjustments are some of the sought-after solutions due to this heightened awareness.

Restraints

Despite significant growth potential, the menopause market faces various challenges that may hinder its expansion. Safety concerns, lack of awareness and stigma, regulatory hurdles, and limited research and development are some of the factors contributing to these challenges.

Safety concerns have arisen regarding hormone replacement therapy (HRT), as studies have linked its use to higher risks of breast cancer, heart disease, and stroke in women. This has led to a growing demand for non-hormonal treatments, posing a challenge for businesses specializing in hormone-based therapies to address these safety issues effectively.

Menopause remains a taboo subject in many countries, leading to limited awareness and understanding of its impact on women's health. The lack of awareness and stigma surrounding menopause may reduce demand and make it difficult for businesses to effectively promote menopause goods and services.

The menopause market is subject to stringent regulatory standards, particularly for hormone-based treatments. Companies developing new medications and therapies must undergo rigorous safety and efficacy evaluations before receiving approval for use. Meeting these regulatory requirements can be a challenging process for market players.

Market Trends

Due to growing concerns about the potential risks associated with hormone-based treatments, an increasing number of women are seeking non-hormonal alternatives to manage the symptoms of menopause. This has led to a rising demand for non-hormonal therapies, including herbal medicines, cognitive-behavioral therapy (CBT), and mindfulness-based treatments, as effective options for addressing menopausal symptoms.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Menopause Market by Applications
  • Market Overview
  • Screening and Diagnosis
• Global Menopause Market by End User
  • Market Overview
  • Hospital
  • Diagnostic Centres
  • Specialty Clinics
  • Others.
• Global Menopause Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Pfizer Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Novo Nordisk A/S
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Allergan plc
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • TherapeuticsMD Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mylan N.V.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teva Pharmaceutical Industries Ltd.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bayer AG
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck & Co. Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Johnson & Johnson
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • GlaxoSmithKline plc
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Amgen Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • AbbVie Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pfizer Inc.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Novartis International AG
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Procter & Gamble Co.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Roche Holding AG
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi SA
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Serenity Pharmaceuticals LLC
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mithra Pharmaceuticals SA
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • In Feb 2022, Nestle Health Science has completed the final acquisition of Vital Proteins, the one of the leading company in collagen in the United States and a lifestyle and wellness platform offering supplements, beverages and food products. Nestle Health Science acquired a majority stake in Vital Proteins in 2020.
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • In 2022, TherapeuticsMD, Inc. (NYSE MKT: TXMD), an women's healthcare company, announced positive top-line results from its pivotal phase 3 Replenish Trial of TX-001HR, an investigational bio-identical hormone therapy combination of 17B-estradiol and progesterone in a single, oral softgel, for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause in post-menopausal women with an intact uterus
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments